Risk and benefits of taking part
Benefits:
We cannot promise the trial will help you directly but the information we get from this study may help us to prevent group B Strep infection in new-born babies better in the future.
The results of this trial may also influence UK strategy for group B Strep treatment.
Risks:
The swabbing may be mildy uncomfortable but there is no foreseeable risk of harm to either you or your baby.
As with all medications, there is a risk of a drug reaction from the antibiotics you may be offered if your test results for group B Strep are positive. However, these antibiotics are approved for use in the UK and the side effects are well known.